Bristol-Myers Squibb Co

Bristol Myers Squibb 's earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock. But it was enough, for now. Revenue in the first quarter, which ended March 31, dipped 6% to $11.2 billion but topped…

Financial markets have been roiled over the past month on escalating concerns about a recession and a global trade war because of President Donald Trump 's constantly shifting tariff plans. Since our Monthly Meeting on March 13, Wall…

The Lilly Biotechnology Center in San Diego, California, on March 1, 2023.Mike Blake | ReutersShares of some drugmakers rose on Wednesday after President Donald Trump said he would pause steep tariff rates on dozens of countries,…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: Stocks are struggling to hold onto gains Tuesday with…

Jim Cramer ran through all 32 companies in the Investing Club portfolio during the March Monthly Meeting on Thursday, but he gave special focus to six of his favorite stocks to buy right now: TJX Companies, Capital One Financial, Texas…

President Donald Trump arrives in the Brady Press Briefing Room at the White House on Jan. 30, 2025 in Washington, DC.Oliver Contreras | Afp | Getty ImagesPresident Donald Trump likely won't do away with a landmark process that allows…

A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. George Frey | ReutersThe Biden administration on Friday unveiled the next 15 prescription drugs that will be subject to price negotiations…

The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty ImagesBristol Myers Squibb believes Alzheimer's is the largest…

Another earning season is over. The winners? Most of our stocks. Twenty-three out of 33 portfolio names delivered third-quarter reports were deemed good or great by the Investing Club, thanks partly to a still-strong consumer and largely…